Neuronetics, Inc.
STIM
$4.48
$0.245.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.73% | 3.61% | -6.59% | 12.08% | 11.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.73% | 3.61% | -6.59% | 12.08% | 11.63% |
| Cost of Revenue | 164.85% | -26.00% | -11.68% | 4.46% | -39.79% |
| Gross Profit | -12.33% | 19.02% | -4.66% | 14.85% | 27.98% |
| SG&A Expenses | 14.46% | 4.51% | 3.90% | -4.94% | -2.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.08% | -1.86% | -0.01% | -4.60% | -11.90% |
| Operating Income | -330.23% | 12.88% | -15.76% | 30.77% | 67.30% |
| Income Before Tax | -135.84% | -42.06% | -100.61% | 25.16% | 35.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -135.84% | -42.06% | -100.61% | 25.16% | 35.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.48% | -42.06% | -100.61% | 25.16% | 35.14% |
| EBIT | -330.23% | 12.88% | -15.76% | 30.77% | 67.30% |
| EBITDA | -397.45% | 13.99% | -15.95% | 32.93% | 70.73% |
| EPS Basic | -86.55% | -35.55% | -90.90% | 28.83% | 39.25% |
| Normalized Basic EPS | -231.55% | 9.44% | -19.94% | 28.78% | 60.71% |
| EPS Diluted | -86.55% | -35.55% | -90.90% | 28.83% | 39.25% |
| Normalized Diluted EPS | -231.55% | 9.44% | -19.94% | 28.78% | 60.71% |
| Average Basic Shares Outstanding | 26.25% | 4.82% | 5.11% | 5.13% | 6.77% |
| Average Diluted Shares Outstanding | 26.25% | 4.82% | 5.11% | 5.13% | 6.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |